Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Cipla
Healthtrust
Daiichi Sankyo
Argus Health
AstraZeneca
Medtronic
Citi

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,243,054

« Back to Dashboard

Title: Compound which is angiotensin II antagonist
Abstract:
Inventor(s): Naka; Takehiko (Kobe, JP), Inada; Yoshiyuki (Kawanishi, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Filing Date:Jun 25, 1992
Application Number:07/904,452
Claims:1. The compound 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]meth yl]benzimidazole-7-carboxylic acid.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Citi
AstraZeneca
Mallinckrodt
Accenture
US Army
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.